Collegium Pharmaceutical Inc (COLL)
33.55
+0.09
(+0.27%)
USD |
NASDAQ |
Nov 04, 13:08
Collegium Pharmaceutical Profit Margin (Quarterly): 13.50% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 13.50% |
| March 31, 2024 | 19.12% |
| December 31, 2023 | 21.33% |
| September 30, 2023 | 15.09% |
| June 30, 2023 | 9.60% |
| March 31, 2023 | -12.04% |
| December 31, 2022 | -5.55% |
| September 30, 2022 | 0.36% |
| June 30, 2022 | -4.20% |
| March 31, 2022 | -15.60% |
| December 31, 2021 | -91.49% |
| September 30, 2021 | 10.21% |
| June 30, 2021 | 87.82% |
| March 31, 2021 | 17.85% |
| December 31, 2020 | 9.12% |
| September 30, 2020 | 14.25% |
| Date | Value |
|---|---|
| June 30, 2020 | 10.32% |
| March 31, 2020 | 0.59% |
| December 31, 2019 | -2.97% |
| September 30, 2019 | -8.38% |
| June 30, 2019 | -6.28% |
| March 31, 2019 | -13.02% |
| December 31, 2018 | 12.37% |
| September 30, 2018 | -23.52% |
| June 30, 2018 | -17.88% |
| March 31, 2018 | -29.26% |
| December 31, 2017 | -161.2% |
| September 30, 2017 | -111.0% |
| June 30, 2017 | -593.3% |
| March 31, 2017 | -1.06K% |
| December 31, 2016 | -2.12K% |
| September 30, 2016 | -6.48K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-91.49%
Minimum
Dec 2021
87.82%
Maximum
Jun 2021
5.12%
Average
9.60%
Median
Jun 2023
Profit Margin (Quarterly) Benchmarks
| Rigel Pharmaceuticals Inc | -2.80% |
| Esperion Therapeutics Inc | -83.87% |
| Context Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 49.26% |
| Return on Assets | 8.76% |
| Return on Invested Capital | 11.55% |
| Gross Profit Margin (Quarterly) | 62.51% |
| Operating Margin (Quarterly) | 32.68% |
| Return on Net Operating Assets | 12.53% |